The research focus of Huang’s team is to elucidate cellular and molecular events in initiation and progression of endothelial cell dysfunction in hypertension, obesity, and diabetes, to uncover novel biomarkers for vascular pathogenesis, and to develop venues to reverse vascular dysfunction in animal models of cardio-metabolic disorders. He has co-authored 491 peer-reviewed publications in SCI-indexed journals including Nature, Science, Cell Metabolism, Circulation Research, European Heart Journal, PNAS, Diabetes, Hypertension, ATVB, Stroke with 32766 Google scholar citations (h-index of 93).

Prof. Huang received 2020 Wuxi PharmaTech Life Science and Chemistry Award – The Scholar Award (2020年度藥明康德生命化學研究獎學者獎), Higher Education Outstanding Scientific Research Output Award (first-class award in 2019, 2019年度高等學校科學研究优秀成果獎 – 自然科學一等獎, second-class awards in 2017 and 2012), 2017及2012年度高等學校科學研究优秀成果獎 – 自然科學二等獎, Ministry of Education, China, The State Natural Science Award (second-class award in 2015, 2015年度國家自然科學獎二等獎), China; The Croucher Award – Croucher Senior Research Fellowship ((香港裘槎基金會裘槎優秀科研者獎, 2014). He was also the recipient of The Keynote Lecture at 19th World Congress of Basic and Clinical Pharmacology (WCP2023, Glasgow, Scotland, 2023), The Asian Lecture on Vascular Biology, Shanghai (2018), The Robert F. Furchgott Lecture, Zurich (2013), and The Office of Life Sciences Distinguished Lecture, National University of Singapore, Singapore (2007).